Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | |
---|---|---|---|---|---|---|---|---|
TJC of 28 joints | 4 | 6 | 25 | 16 | 12 | 23 | 4 | 17 |
SJC of 28 joints | 3 | 6 | 4 | 12 | 6 | 20 | 15 | 7 |
VAS general disease activity | 47 | 19 | 87 | 71 | 59 | 89 | 70 | 67 |
ESR (mm/h) | 35 | 6 | 97 | 14 | 10 | 43 | 58 | 16 |
C reactive protein (mg/l) | 4.6 | 7.2 | 85.6 | 5.9 | 5.1 | 17.5 | 34.7 | 3.0 |
DAS28 | 4.75 | 3.58 | 7.58 | 5.91 | 5.06 | 7.82 | 6.03 | 5.3 |
Sex (0=male) | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
Age (years) | 59 | 53 | 39 | 58 | 47 | 53 | 53 | 54 |
Disease duration (months) | 114 | 264 | 132 | 42 | 456 | 168 | 276 | 156 |
Rheumatoid factor (1=positive) | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
Erosive disease (1=yes) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
DAS28, disease activity score in 28 joints; ESR, erythrocyte sedimentation rate; SJC, swollen joint count; TJC, tender joint count; VAS, visual analogue scale.